Back to search

Article

Prognostic Value of IGFBP6 in Breast Cancer: Focus on Glucometabolic

2023-09-14

Abstract excerpt

IGFBP6, as a member of the IGF binding proteins (IGFBPs) family, is a specific inhibitor of insulin-like growth factor II (IGF-II) and can inhibit the growth of malignant tumors overexpressing IGF-II. Type 2 diabetes (T2D) is a basic disorder of glucose metabolism which is regulated by IGF-related pathways. IGFBP6 expression is downregulated in serum and tumor tissue of colorectal cancer patients with T2D. We anal...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c90ca60b-66ea-5c27-8c6c-7f5d7b845c56
DOI
10.21203/rs.3.rs-3274239/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prognostic Value of IGFBP6 in Breast Cancer: Focus on GlucometabolicDOI 10.21203/rs.3.rs-3274239/v1
Select a neighboring publication to make it the new centre.